Clinical Trial Update: A Study of V110 a Pneumococcal Vaccine in Healthy Adults (V110-013) [Phase 3]

View source ↗

Summary

Phase 3 study of the V110 pneumococcal vaccine in healthy adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Infections

Drugs mentioned

• V110

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Healthy, Pneumococcal Infections | Phase 3 | Status: COMPLETED